Serum Lipid Profiles of Patients Taking Efavirenz-Based Antiretroviral Regimen Compared to Ritonavir-Boosted Atazanavir with an Optimized Background at Zewditu Memorial Hospital, Addis Ababa, Ethiopia

BACKGROUND: Dyslipidemia represents significant health care concerns in patients taking antiretroviral therapy due to their association with cardiovascular disease risk. There is limited data regarding the effects of boosted atazanavir (ATV/r) treatment in the lipid profiles of Ethiopian HIV patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:HIV AIDS (Auckl)
Main Authors: Muche Belete, Abebe, Seifu, Daniel, Menon, Menakath, Amogne, Wondwossen, Shewa, Aster, Adela Tefera, Alemu
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903961/
https://ncbi.nlm.nih.gov/pubmed/33642881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HIV.S296170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados